Block/NN
of/IN
granulocytic/JJ
differentiation/NN
of/IN
32Dcl3/NN
cells/NNS
by/IN
AML1/ETO/NN
(/(
MTG8/NN
)/)
but/CC
not/RB
by/IN
highly/RB
expressed/VBN
Bcl-2/NN
./.

The/DT
chimeric/JJ
gene/NN
,/,
AML1/ETO/NN
(/(
MTG8/NN
)/)
,/,
generated/VBN
in/IN
t(8;21)/NN
acute/JJ
myeloid/JJ
leukemia/NN
enhances/VBZ
the/DT
expression/NN
of/IN
Bcl-2/NN
./.
=====
To/TO
evaluate/VB
whether/IN
this/DT
enhancement/NN
is/VBZ
the/DT
primary/JJ
role/NN
of/IN
AML1/ETO/NN
in/IN
leukemogenesis/NN
,/,
effects/NNS
of/IN
over-expression/NN
of/IN
Bcl-2/NN
in/IN
the/DT
murine/JJ
myeloid/JJ
precursor/NN
cell/NN
line/NN
,/,
32Dcl3/NN
,/,
were/VBD
examined/VBN
./.
=====
When/WRB
32Dcl3/NN
cells/NNS
expressing/VBG
exogenous/JJ
Bcl-2/NN
were/VBD
induced/VBN
to/TO
differentiate/VB
,/,
the/DT
onset/NN
of/IN
morphological/JJ
differentiation/NN
was/VBD
delayed/VBN
./.
=====
However/RB
,/,
even/RB
the/DT
cells/NNS
expressing/VBG
very/RB
high/JJ
levels/NNS
of/IN
exogenous/JJ
Bcl-2/NN
eventually/RB
underwent/VBD
differentiation/NN
without/IN
a/DT
significant/JJ
decrease/NN
in/IN
the/DT
synthesis/NN
of/IN
Bcl-2/NN
./.
=====
On/IN
the/DT
contrary/NN
,/,
32Dcl3/NN
cells/NNS
stably/RB
expressing/VBG
AML1/ETO/NN
were/VBD
completely/RB
resistant/JJ
to/TO
differentiation/NN
and/CC
continued/VBD
to/TO
grow/VB
in/IN
the/DT
presence/NN
of/IN
G-CSF/NN
./.
=====
These/DT
results/NNS
are/VBP
consistent/JJ
with/IN
the/DT
interpretation/NN
that/IN
stimulation/NN
of/IN
Bcl-2/NN
expression/NN
is/VBZ
not/RB
the/DT
primary/JJ
target/NN
of/IN
AML1/ETO/NN
./.